myze launches The Daily Lid Wipe, created with input from eye care professionals

News
Article

The lid wipe contains tea tree oil, hyaluronic acid, and other antibacterial and antimicrobial ingredients like euphrasia, chamomile, and rhamnose

Image credit: AdobeStock/Kabardinsphoto

Image credit: AdobeStock/Kabardinsphoto

Digital health platform myze has announced the launch of its first branded product, The Daily Lid Wipe, a modern lid wipe that contains tea tree oil, hyaluronic acid, and other antibacterial and antimicrobial ingredients like euphrasia, chamomile, and rhamnose. According to the news release, the wipe was formulated with the input of Laura M. Periman, MD and Cecelia Koetting, OD, FAAO, Dipl ABO.1

“Both my patients and I are really enjoying The Daily Lid Wipe from Myze,” Koetting said. “The formula is gentle, and the cloth's texture is enough to remove dirt and debris but soft without irritating the skin.”

The wipe is also “uniquely soft and gentle, yet highly effective in removing debris, leaving the eye area feeling cleansed and refreshed,1” the release stated.

“We have a very simple, yet audacious mission at myze: to make eye care part of everyone’s daily self care routine,” said Scott Tannenbaum, CEO and founder of myze. “After speaking to our customers for the last several years, it became quite apparent that there is a huge unmet need to educate on the importance of lid hygiene and provide customers access to a product that is unique and modern. The Daily Lid Wipe meets this need.”

Benjamin Chudner, chief medical officer of AEG Vision, reinstated this unmet need regarding patient education, including eyelid and lash hygiene and its impact on ocular surface disease. “We are partnering with myze and their new product launch, The Daily Lid Wipe, to ensure that our patients are getting the best possible products for their daily lid hygiene needs,” he said in the release.

Reference:
  1. Myze launches The Daily Wipe to make daily eye lid hygiene an integral part of daily self care for millions of patients. News release. myze. October 30, 2024. Accessed November 21, 2024.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Susana Marcos, PhD, discusses the implications her research presents for the role optical coherence tomography (OCT) could play in presbyopia and myopia accommodation efforts.
Susana Marcos, PhD, outlines a presentation she gave at ARVO 2025 on a unique utilization of optical coherence tomography.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
At CIME 2025, Selina McGee, OD, FAAO, says some patients underestimate oculoplastic care. She stands in front of a sign that says Controversies in Modern Eye Care 2025.
Patricia Buehler, MD, MPH, at ASCRS 2025
© 2025 MJH Life Sciences

All rights reserved.